BNTC
Benitec Biopharma Inc.
Key Financials
Revenue
$59000
↓ 42.2%
Net Income
$-37917000
↓ 330.6%
Operating Income
$-41765000
↓ 324.7%
EPS (Diluted)
$-1.05
↓ 400.0%
Total Liabilities
$2.3M
↓ 53.7%
Shareholders' Equity
$97.3M
↑ 105.9%
Total Assets
$99.6M
↑ 90.8%
Cash & Equivalents
$97.7M
↑ 92.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K/A | 3/20/2026 | View on SEC |
| 8-K | 2/12/2026 | View on SEC |
| 10-Q | 2/12/2026 | View on SEC |
| 424B3 | 2/11/2026 | View on SEC |
| EFFECT | 2/10/2026 | View on SEC |
| S-3 | 1/30/2026 | View on SEC |
| SCHEDULE 13G/A | 1/29/2026 | View on SEC |
| 4 | 1/26/2026 | View on SEC |
| 4 | 12/29/2025 | View on SEC |
| 4 | 12/22/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BNTC |
| Company Name | Benitec Biopharma Inc. |
| CIK | 1808898 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | (510) 780-0819 |